Coherent Diagnostic Technology, a developer of optical coherence tomography (OCT) systems for medical imaging applications, is changing its name to LightLab Imaging. Paul Magnin, president and CEO of LightLab, said his company predicts that light will
Coherent Diagnostic Technology, a developer of optical coherence tomography (OCT) systems for medical imaging applications, is changing its name to LightLab Imaging. Paul Magnin, president and CEO of LightLab, said his company predicts that light will have an important role in imaging and medicine, and the new name better captures this movement.
Systems using OCT have already been deployed for use in ophthalmic applications (SCAN 9/1/99). The FDA is reviewing several LightLab Imaging products using OCT for market clearance. In addition, the company has products in the pipeline that it will submit to the FDA in the near future, according to a company spokesperson.
Can AI Facilitate Single-Phase CT Acquisition for COPD Diagnosis and Staging?
December 12th 2024The authors of a new study found that deep learning assessment of single-phase CT scans provides comparable within-one stage accuracies to multiphase CT for detecting and staging chronic obstructive pulmonary disease (COPD).
Assessing MACE Risk in Women: Can an Emerging Model with SPECT MPI Imaging Have an Impact?
December 9th 2024In research involving over 2,200 women who had SPECT MPI exams, researchers found that those who had a high score with the COronary Risk Score in WOmen (CORSWO) model had a greater than fourfold higher risk of major adverse coronary events (MACE).